Evaluation of reproductive health status of HPV-vaccinated girls in the Republic of Kazakhstan

Authors

  • A.R. Satanova КазНИИОиР
  • Т.Т. Sadykova
  • K. Toleutaiuly
  • Y.K. Kukubassov
  • R.O. Bolatbekova
  • D.R. Kaidarova

Keywords:

human papillomavirus, reproductive health, vaccination

Abstract

Relevance: The safety of human papillomavirus (HPV) vaccination for vaccinated girls is emphasized by the need to educate the public about facts that counter myths and concerns associated with the vaccine. Recent studies have found no link between HPV vaccination and adverse effects, such as adverse effects on girls’ reproductive health and decreased fertility. This confirms the safety of vaccination in preventing cervical cancer and also highlights the importance of continuing vaccination programs and information campaigns to support public health.

The study aimed to assess of reproductive health in vaccinated girls against HPV in 2013-2015.

Methods: A survey of girls vaccinated against HPV in 2013-2015 was conducted through questionnaires in Almaty, Pavlodar, and Astana.

Results: According to the study results, the percentage of girls with menstrual dysfunction was lower among vaccinated (5.6%) than among unvaccinated (11.2%). There is also a higher willingness of vaccinated girls to vaccinate their children against HPV (43.5% versus 29.9%), indicating their high awareness and readiness for prevention. Thus, HPV vaccination did not have a negative impact on the reproductive health of girls.

Conclusion: According to our study, vaccination against HPV does not affect the reproductive potential of girls vaccinated against HPV. It is associated with a lower risk of developing HPV-related diseases and does not have negative consequences on reproductive health. HPV vaccination is an important cervical cancer prevention measure with proven safety and effectiveness.

Downloads

Published

06.09.2024